Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

A phase II, randomized, double-blind, parallel-group, placebo-controlled, oral food challenge trial of Xolair, (omalizumab) in peanut allergy (TOPS)

Sampson HA, Leung DYM, Burks W, Lack G, Bahma SL, Jones SM, Varshavsky J, Wong DA, Deniz Y, TOPS Study Group. A phase II, randomized, double-blind, parallel-group, placebo-controlled, oral food challenge trial of Xolair, (omalizumab) in peanut allergy (TOPS). J Allergy Clin Immunol. 2007; S117.


collapse authors with profiles